Across TCGA pan-cancer cohorts, DTNB RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of DTNB’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where DTNB RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DTNB is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.
COAD, BLCA, and KIRC are the cancer types where DTNB tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DTNB RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.